Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT02390752
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
54 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Neurofibroma, Plexiform


Precursor Cell Lymphoblastic Leukemia-Lymphoma


Leukemia, Promyelocytic, Acute


Sarcoma
COMPLETED
NCT07874555
A Real World Evidence Retrospective Data Collection Study of Edoxaban and Rivaroxaban
8,265 Enrollment(s)
2 Study location(s)
OBSERVATIONAL (None)
Atrial Fibrillation


Renal Dysfunction
RECRUITING
NCT07086768
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
57 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Solid Tumor


Advanced Solid Tumor


Metastatic Solid Tumor
COMPLETED
NCT06812117
A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)
721 Enrollment(s)
43 Study location(s)
OBSERVATIONAL (None)
Diabetic Peripheral Neuropathic Pain
RECRUITING
NCT07578116
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
562 Enrollment(s)
59 Study location(s)
INTERVENTIONAL (PHASE3)
Anatomic Stage IV Breast Cancer AJCC v8


Metastatic HER2-Positive Breast Carcinoma


Oligometastatic Breast Carcinoma
ENROLLING_BY_INVITATION
NCT07547878
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
64 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Chronic Kidney Disease


Type 2 Diabetes
RECRUITING
NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
600 Enrollment(s)
257 Study location(s)
INTERVENTIONAL (PHASE3)
Endometrial Cancer
RECRUITING
NCT06467357
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
620 Enrollment(s)
272 Study location(s)
INTERVENTIONAL (PHASE3)
Biliary Tract Cancer